The proposed new facility, expected to be operational by 2012, is expected to be Novartis’s biggest investment in its manufacturing capacity.
A $180 million plant that manufactures Novartis tablets has already become operational in Singapore.
The proposed new facility, expected to be operational by 2012, is expected to be Novartis’s biggest investment in its manufacturing capacity.
A $180 million plant that manufactures Novartis tablets has already become operational in Singapore.